Lanifibranor Recruiting Phase 2 Trials for Type 2 Diabetes Mellitus / Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03459079Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease